Literature DB >> 6023771

Peroxidative hemolysis of red blood cells from patients with abetalipoproteinemia (acanthocytosis).

J T Dodge, G Cohen, H J Kayden, G B Phillips.   

Abstract

The effect of peroxidative stress on tissue was studied by exposure of red blood cells (RBC) from patients with abetalipoproteinemia to minute amounts of H(2)O(2)in vitro. Red blood cells from untreated patients showed a marked sensitivity to H(2)O(2), as evidenced by hemolysis and lipid peroxidation (peroxidative hemolysis). The appearance of lipid peroxidation products in sensitive cells after exposure to H(2)O(2) was indicated by 1) increases in the 2-thiobarbituric acid (TBA) reaction of trichloroacetic acid extracts, 2) increases in ultraviolet light absorbency of lipid extracts, and 3) decreases in polyunsaturated fatty acids. These changes were accompanied by a decrease in phosphatidyl ethanolamine and phosphatidyl serine in the RBC lipid extract. Similar lipid changes on exposure to H(2)O(2) were observed in the RBC from vitamin E-deficient rats. Treatment of the patients with d-alpha-tocopherol polyethylene glycol succinate by mouth, or addition of dl-alpha-tocopherol to the incubation medium protected the RBC from peroxidative hemolysis. Tocopherol appears to provide a primary biologic defense against peroxidative hemolysis. The presence of nitrite or carbon monoxide, which produced methemoglobin and carboxyhemoglobin, respectively, inhibited peroxidative changes, suggesting a catalytic role for oxy- or deoxyhemoglobin. Substances that prevented lipid peroxidation also prevented hemolysis; in addition, lipid peroxidation appeared to precede hemolysis. These observations suggested that hemolysis was a consequence of lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023771      PMCID: PMC297056          DOI: 10.1172/JCI105537

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  CONGENITAL BETA-LIPOPROTEIN DEFICIENCY: AN HEREDITARY DISORDER INVOLVING A DEFECT IN THE ABSORPTION AND TRANSPORT OF LIPIDS.

Authors:  K J ISSELBACHER; R SCHEIG; G R PLOTKIN; J B CAULFIELD
Journal:  Medicine (Baltimore)       Date:  1964-05       Impact factor: 1.889

2.  COD LIVER OIL FATTY ACIDS AS SECONDARY REFERENCE STANDARDS IN THE GLC OF POLYUNSATURATED FATTY ACIDS OF ANIMAL ORIGIN: ANALYSIS OF A DERMAL OIL OF THE ATLANTIC LEATHERBACK TURTLE.

Authors:  R G ACKMAN; R D BURGHER
Journal:  J Am Oil Chem Soc       Date:  1965-01       Impact factor: 1.849

3.  RED-CELL AND PLASMA LIPIDS IN ACANTHOCYTOSIS.

Authors:  P WAYS; C F REED; D J HANAHAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

4.  DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE, MACULAR ATROPHY AND ACANTHOCYTOSIS (BASSEN-KORNZWEIG SYNDROME).

Authors:  L A SOBREVILLA; M L GOODMAN; C A KANE
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

5.  Human erythrocyte phosphoglycerides. I. Quantification of plasmalogens, fatty acids and fatty aldehydes.

Authors:  J W FARQUHAR
Journal:  Biochim Biophys Acta       Date:  1962-06-18

6.  The protective action of tocopherol against hemolysis of rat erythrocytes by dialuric acid.

Authors:  C C TSEN; H B COLLIER
Journal:  Can J Biochem Physiol       Date:  1960-09

7.  The lipoproteins and lipid transport in abetalipoproteinemia.

Authors:  R I Levy; D S Fredrickson; L Laster
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

8.  Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide.

Authors:  N L Somerson; B E Walls; R M Chanock
Journal:  Science       Date:  1965-10-08       Impact factor: 47.728

9.  Characterization and quantification of red cell lipids in normal man.

Authors:  P Ways; D J Hanahan
Journal:  J Lipid Res       Date:  1964-07       Impact factor: 5.922

10.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

View more
  26 in total

1.  Effects of phospholipase C on human erythrocytes.

Authors:  M H Bowman; A C Ottolenghi; C E Mengel
Journal:  J Membr Biol       Date:  1971-12       Impact factor: 1.843

2.  Decreased fluidity of red cell membrane lipids in abetalipoproteinemia.

Authors:  R A Cooper; J R Durocher; M H Leslie
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Oxygen-mediated heterogeneity of apo-low-density lipoprotein.

Authors:  J Schuh; G F Fairclough; R H Haschemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 4.  Disorders of the serum lipoproteins. I. Lipoprotein deficiency states.

Authors:  J K Lloyd
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

5.  Lipid-peroxidation in Spielmeyer-Vogt's disease.

Authors:  J C Pronk; E Hooyen-Bosma; G W Edgar
Journal:  Humangenetik       Date:  1973-09-20

6.  Changes in microsomal lipids of rat liver after chronic carbon tetrachloride intoxication.

Authors:  M Comporti; G Landucci; F Raja
Journal:  Experientia       Date:  1971-10-15

7.  Abnormalities of high density lipoproteins in abetalipoproteinemia.

Authors:  J W Jones; P Ways
Journal:  J Clin Invest       Date:  1967-07       Impact factor: 14.808

8.  In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats.

Authors:  S K Jain
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Significance of an in vitro phenomenon in which murine erythrocytes are lysed by autologous spleen cells and spherules of Coccidioides immitis.

Authors:  D L Danley; A E Hilger; P Boonlayangoor; E W Millhouse
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  The relative importance of the factors involved in the absorption of vitamin E in children.

Authors:  D P Muller; J T Harries; J K Lloyd
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.